Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome

scientific article published on 01 August 1999

Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/314872
P698PubMed publication ID10395857

P2093author name stringAndersson J
Holm SE
Norgren M
Eriksson BK
P433issue2
P921main subjecttoxic shock syndromeQ1128440
streptococcal infectionQ5849703
P304page(s)410-418
P577publication date1999-08-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleInvasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome
P478volume180

Reverse relations

cites work (P2860)
Q34184576Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1
Q35203877Bacterial superantigens
Q35176156Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.
Q35554868Characterization of the interaction of staphylococcal enterotoxin B with CD1d expressed in human renal proximal tubule epithelial cells
Q36423634Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.
Q36483622Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis
Q34575978Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection
Q42956870Dynamics of the immune response against extracellular products of group A streptococci during infection
Q92965671Elevated risk of invasive group A streptococcal disease and host genetic variation in the human leucocyte antigen locus
Q34004799Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases
Q79162722Group A Streptococcal Infections in Sweden: A Comparative Study of Invasive and Noninvasive Infections and Analysis of Dominant T28 emm28 Isolates
Q35142053Group A Streptococci: A rare and often misdiagnosed cause of spontaneous bacterial peritonitis in adults
Q35083669Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies
Q36216880Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin
Q35585106Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections
Q37387611Intravenous immunoglobulin in children with streptococcal toxic shock syndrome
Q58863452Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum
Q27470020Involvement of Streptococcal Mitogenic Exotoxin Z in Streptococcal Toxic Shock Syndrome
Q35097527Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality
Q33897047Pleural empyema and streptococcal toxic shock syndrome due to Streptococcus pyogenes in a healthy Spanish traveler in Japan
Q37099562Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland
Q38508472Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection
Q57821755Sepsis and Pleural Empyema Caused by after Influenza A Virus Infection
Q37624377Streptococcal pyrogenic exotoxin B-induced apoptosis in a549 cells is mediated by a receptor- and mitochondrion-dependent pathway
Q84855338Streptococcus pyogenes bacteraemia, emm types and superantigen profiles
Q24795896Superantigen antagonist peptides
Q42106655Superantigens and streptococcal toxic shock syndrome
Q34123105Superantigens: microbial agents that corrupt immunity
Q40488735The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications.
Q34556079Toxic shock syndrome in children: epidemiology, pathogenesis, and management
Q33971210Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden
Q40504901Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity

Search more.